Kits
Urine BETA CrossLaps® (CTX-I) ELISA
Kits
Description
The Urine BETA CrossLaps® (CTX-I) ELISA is an enzyme immunological test for the quantification of degradation products of C-terminal telopeptides of Type-I collagen in human urine1, 2, 3.
The Urine BETA CrossLaps® (CTX-I) ELISA assay is intended for in vitro diagnostic use as an indication of human bone resorption as an aid in:
A. Monitoring bone resorption changes of
a. Anti-resorptive therapies in postmenopausal women:
Hormone Replacement Therapies (HRT) with hormones and hormone-like drugs
Bisphosphonate therapies
B. Predicting skeletal response (Bone Mineral Density) in postmenopausal women undergoing anti-resorptive therapies
a. Hormone Replacement Therapies (HRT) with hormones and hormone-like drugs
b. Bisphosphonate therapies
The Urine BETA CrossLaps® (CTX-I) ELISA assay is intended for in vitro diagnostic use as an indication of human bone resorption as an aid in:
A. Monitoring bone resorption changes of
a. Anti-resorptive therapies in postmenopausal women:
Hormone Replacement Therapies (HRT) with hormones and hormone-like drugs
Bisphosphonate therapies
B. Predicting skeletal response (Bone Mineral Density) in postmenopausal women undergoing anti-resorptive therapies
a. Hormone Replacement Therapies (HRT) with hormones and hormone-like drugs
b. Bisphosphonate therapies